Glioblastoma (GBM) is the most aggressive and common form of primary brain tumor in adults, representing a significant challenge in neuro-oncology. Characterized by rapid growth, infiltrative behavior, and resistance to conventional therapies, glioblastoma carries a poor prognosis, with median survival typically less than 15 months despite aggressive treatment. Advances in molecular biology,...